ONO-2952 Single-dose PET Study in Healthy Adult Subjects

Summary

The primary objective of this study is to evaluate the brain TSPO occupancy of ONO-2952 in healthy adult subjects after a single dose using \[11C\]PBR28 as a specific PET ligand for TSPO. The secondary objective is to evaluate the relationship between TSPO occupancy and the plasma concentration of ONO-2952 and to investigate the safety and tolerability of ONO-2952 in healthy subjects.

Timeline

Start

2012-08

Primary completion

2013-03

Completion

—

Drugs

Indications

No indication recorded.